10678 Federal Register / Vol. 70, No.
42 / Friday, March 4, 2005 / Notices
Drug
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (non-
dosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. sections 823(a) and
952(a) and determined that the
registration of Cerilliant Corporation to
import the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Cerilliant Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
class of controlled substance listed.
Dated: February 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4234 Filed 3–3–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By notice dated September 28, 2004,
and published in the Federal Register
on October 13, 2004, (69 FR 60898),
Chattem Chemicals, Inc., 3801 St. Elmo
Avenue, Building 18, Chattanooga,
Tennessee 37409, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
VerDate jul<14>2003 19:07 Mar 03, 2005 Jkt 205001
Schedule of controlled substances listed in
Schedules I and II:
II
II Drug
II
II N-Ethylamphetamine (1475) ........
II 4-Methoxyamphetamine (7411) ...
2,5-Dimethoxyamphetamine
II
II (7396).
Difenoxin (9168) ...........................
II Amphetamine (1100) ....................
II Methamphetamine (1105) ............
Methylphenidate (1724) ................
II
Pentobarbital (2270) .....................
II
Secobarbital (2315) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Diphenoxylate (9170) ...................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Dextropropoxyphene, bulk (9273)
Morphine (9300) ...........................
Thebaine (9333) ...........................
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chattem Chemicals, Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Chattem Chemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4230 Filed 3–3–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated November 8, 2004,
and published in the Federal Register
on November 22, 2004, (69 FR 67962–
PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 E:\FR\FM\04MRN1.SGM
67963), ISP, Freetown Fine Chemicals,
Inc., 238 South Main Street, Assonet,
Massachusetts 02702, made application
Schedule by renewal to the Drug Enforcement
Administration (DEA) for registration as
I a bulk manufacturer of the basic classes
I
I of controlled substances listed in
Schedules I and II:
I
II Drug Schedule
II
II 2,5-Dimethoxyamphetamine I
II (7396).
II Amphetamine (1100) .................... II
II Phenylacetone (8501) .................. II
II
II The company plans to manufacture
II phenylacetone to be used in the
II manufacture of the amphetamine. The
II bulk 2, 5-dimethoxyamphetamine will
II be used for conversion into non-
II
II
controlled substances.
No comments or objections have been
II
II received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of ISP,
Freetown Fine Chemicals, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated ISP, Freetown Fine
Chemicals, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–4197 Filed 3–3–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated November 1, 2004,
and published in the Federal Register
on November 10, 2004, (69 FR 65229),
Guilford Pharmaceuticals, Inc., 6611
Tributary Street, Baltimore, Maryland
21224, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
04MRN1